Development of the isolated dual perfused rat liver model as an improved reperfusion model for transplantation research. 2006

N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
Surgery Research Laboratory, University of Groningen, Groningen, The Netherlands. n.a.hart@path.azg.nl

The Isolated Perfused Liver (IPL) model is a widely used and appreciated in vitro method to demonstrate liver viability and metabolism. Reperfusion is performed in a controlled setting, however, via the portal vein only. To study transplant related questions concerning bile and transport of bile, the in vitro Isolated dual Perfused Liver model is revisited. The IdPL is an in vitro reperfusion model, using both portal vein and hepatic artery. Livers from 12 Wistar rats were flushed with University of Wisconsin-organ preservation solution, procured and reperfused in either the conventional IPL-model (n = 6) or the new IdPL-model (n = 6). Liver injury, assessed by the release of aspartate amino transferase and lactate dehydrogenase, showed similar levels during both IPL and I dPL reperfusion, only alanine amino transferase showed an improvement. Cumulative bile production showed an improvement: 176.3 +/- 8.4 in the IdPL compared to 126.1 +/- 12.2 microg/g-liver in the IPL (p < 0.05). Clearance of phenol red (PR) and taurocholic acid (TC) remained similar. At 90 minutes reperfusion the PR clearance showed 0.11 +/- 0.01 and 0.11 +/- 0.02 mg/30min/g-liver and the TC clearance 1.01 +/- 0.10 and 1.01 +/- 0.07 micromol/ml/30min/g-liver in the IPL and IdPL, respectively. Increasing the reperfusion time beyond the normally used 90 minutes resulted in a significant increase in transaminases and LDH and a decrease in bile production, liver morphology remained intact and glycogen content was appropriate. In conclusion, the IdPL-model showed similar or better results than the IPL-model, but the liver could not endure an extended reperfusion time using the IdPL.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008297 Male Males
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D010637 Phenolsulfonphthalein Red dye, pH indicator, and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems. Phenol Red,Sulfonphthal,Sulphental,Sulphonthal
D002756 Cholagogues and Choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Choleretics,Cholagogues,Cholagogues, Choleretics,Choleretics and Cholagogues,Hydrocholeretics
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic

Related Publications

N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
September 1992, The American surgeon,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
May 2005, Annals of the New York Academy of Sciences,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
January 1988, Journal of investigative surgery : the official journal of the Academy of Surgical Research,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
September 2014, Genetics and molecular research : GMR,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
April 1975, Journal of neurochemistry,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
May 2008, Transplantation proceedings,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
April 1994, Journal of pharmacological and toxicological methods,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
August 2010, Journal of cardiothoracic and vascular anesthesia,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
January 1985, Journal of hepatology,
N A 't Hart, and A van der Plaats, and C Moers, and H G D Leuvenink, and J Wiersema-Buist, and G J Verkerke, and G Rakhorst, and R J Ploeg
February 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!